ADAMA (000553) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
2 Sep, 2026Executive summary
Achieved stable or modestly increased sales in Q3 and 9M 2025, with Q3 sales up 2.4% to $853 million and nine-month sales stable at $2,698 million, while RMB revenues rose 0.62% in Q3 and 0.72% for 9M.
Net loss narrowed substantially, with Q3 net loss down 63.69% to RMB 342 million and nine-month net loss down 77.00% to RMB 423 million, reflecting improved operational efficiency and cost controls.
EBITDA and gross profit margins improved significantly, with Q3 EBITDA up 59% to $97 million and Q3 gross profit up 18% to $242 million; Q3 EBITDA in RMB rose 87.42% to RMB 742 million.
Adjusted net loss improved by $51 million in Q3 and by $142 million over nine months, with adjusted net income turning positive at $29 million for 9M.
Operational efficiencies, strategic transformation initiatives, and the 'Fight Forward' plan drove margin improvements and cost reductions.
Financial highlights
Q3 sales reached $853 million (up 2.4% YoY); 9M sales stable at $2,698 million; Q3 RMB revenues were 6.65 billion, up 0.62% YoY.
Q3 gross profit increased 18% to $242 million; Q3 adjusted gross profit rose 14% to $257 million; Q3 EBITDA up 59% to $97 million and 87.42% to RMB 742 million.
Q3 adjusted operating income was $56 million (6.0% of sales), up from $13 million (1.4%) last year.
Free cash flow remained positive: $5 million in Q3 and $74 million for 9M, despite increased procurement.
Net cash flow from operating activities for 9M was RMB 2.37 billion, down 17.06% YoY.
Outlook and guidance
Gradual recovery in market demand observed in most regions, with volume growth offsetting price declines.
Channel inventory levels have normalized, supporting demand recovery, but pricing pressure persists due to overcapacity and low commodity prices.
Management expects the impact of US tariff policies and regional geopolitical tensions to remain immaterial.
Latest events from ADAMA
- Net profit rebounded to RMB 432.6 million as margins improved despite revenue decline.000553
Q2 2026 - Q1 2026 sales and net profit rose, while EBITDA declined amid higher costs and price pressures.000553
Q1 2026 - EBITDA rose 25% in 2025 despite a 2% sales drop, with strong cash flow and improved margins.000553
Q4 2025 - Q2 2025 saw sales growth, margin expansion, and positive adjusted net income amid price pressure.000553
Q2 2025 - Margins and cash flow improved in Q3 2024 despite lower sales and ongoing pricing pressure.000553
Q3 2024 - Sales fell 16% in H1 2024, but margins and cash flow improved through cost discipline.000553
Q2 2024 - Net profit rebounded and EBITDA rose 21% as margins and cash flow improved despite lower sales.000553
Q1 2025 - Gross and EBITDA margins rose in 2024, with strong cash flow despite lower sales.000553
Q4 2024